Today’s AI Top Pick: XPEV

9/1/2026 · Swing Setup screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

The desk streams live daily· see the schedule →

Today's pick · Swing SetupXPEVBUY NOW8.6 / 109/1/2026

XPEV is the cleanest 'don't chase' swing setup in this pool. It sits at position_in_21bar_range of 0% on both 4h and 1wk and just 11.43% on 1d — this is a stock parked at the bottom of every window, with a -37.73% weekly drawdown and -43.98% YTD, so entry risk is asymmetric to the upside rather than chasing an extended move. Bullish_prob is 1.0 and near_term_bullish is 1.0, the only name in the entire pool with maximum readings on both. The forecast tape is the largest and most consistent in the group: 4h fc_short/mid/long = +66.42% / +69.68% / +97.25%, 1d = +37.94% / +74.62% / +55.69%, and 1wk builds through time from -0.43% short to +28.91% mid to +62.21% long. That is genuine multi-timeframe agreement pointing up, with weekly forecasts strengthening rather than fading. Compare that to KC (also prob 1.0 / near-term 1.0) whose 4h is already at pos 88.54% (chasing) and 1wk mid is only +1.07%, or RARE which has near_term_bullish of 0. The screen thesis is intact: analyst recom 1.67, targetUpsidePct 68.2%, epsNextY 106.38%, salesYoY 28.99%, market cap $8.89B. Yes, fundamental_score is only 0.75 (fwdPe 514, profitMargin -4.21%), and the Barclays underweight with a $14 PT is a real headwind — I'm flagging that. But even that bearish PT sits 24% above the current $11.27, and the China station-wagon expansion headline is a legitimate incremental catalyst. The forecast structure is telling you this is the reflex-bounce candidate. Today is the entry because you're at the exact low-tick of the 21-bar 4h and 1wk ranges with maximum near-term probability — waiting risks losing the -18% drawdown discount. If forecasts are wrong you'll know quickly because there's no room below range-low without a fresh breakdown.

Entry zone

$11.00–$11.50 (near current $11.27, scale in on any dip toward $10.80)

Stop loss

$10.15 (below the 21-bar 4h range floor; ~10% risk)

First target

$14.00 (Barclays PT, +24% — aligns with 1d fc_short +37.94% zone)

Longer target

$18.50–$19.00 (analyst consensus target ~+68%, aligns with 1d fc_mid +74.62% and 1wk fc_long +62.21%)

Risks

Barclays maintained Underweight and cut PT to $14 on 8/26 — 'auto losses deepen' narrative could dominate near-term
fwdPe 514.26 and profitMargin -4.21% mean any China EV demand miss triggers hard multiple compression
recom 1.67 is the weakest of the pool — analyst support is thinner than KC (1.06) or ACMR (1.25)
1wk fc_short is slightly negative (-0.43%) — the very-near-term weekly tape has not turned yet, so first 5–10 sessions could chop
ADR/China regulatory risk and CNY volatility can override any technical setup on headline days

Honorable mentions

RAREFDA approval on gene therapy plus JPM PT raise to $80 and Wells to $50 = real catalyst; bullish_prob 1, 1wk forecasts build to +53.23% long, drawdown -24.81% keeps position at 29.56% (not chasing). Held back by near_term_bullish 0 and -81.79% profitMargin — better BUY_PULLBACK than instant.

KCBullish_prob 1 and near_term_bullish 1 with 1d fc_long +34.79% and 4h fc_long +58.12%, recom 1.06 (best in pool), targetUpside 89.2%, and losses-narrowing narrative. Dinged because 4h pos is already 88.54% — you're chasing on the shortest timeframe.

Full ranking (15)

#	Symbol	Verdict	Score	Read
1	XPEV	BUY NOW	8.6	Bottom-of-range on every TF with prob 1.0 / near-term 1.0 and the biggest forecast magnitudes in the pool (+69% mid 4h, +62% long 1wk).
2	RARE	BUY NOW	7.8	FDA approval + JPM/Wells PT hikes, bullish_prob 1, 1wk fc_long +53.23%, position 24–29% of range — clean catalyst-driven swing.
3	KC	BUY PULLBACK	7.4	Prob 1 / near-term 1, 4h fc_long +58%, recom 1.06 — but 4h pos 88.54% means wait for a pullback into the 1d range low.
4	LUNR	WAIT	6.2	Bullish_prob 1 and 1d fc_mid +21.67%, but 4h and 1wk long forecasts are -13% and -45% — TFs disagree.
5	BTDR	WAIT	5.9	Positive $800M Malaysia AI deal and 1d fc_long +34.72%, but 1wk forecasts are all negative and 1d pos already 73.6%.
6	GLXY	WAIT	5.6	1d fc_long +18.33% and constructive crypto narrative but bullish_prob null and no 1wk tape to confirm.
7	ATAT	BUY PULLBACK	5.2	Best fundamentals (score 8, PEG 0.64, ROE 58.78) but 4h pos 96.78% and 1wk fc_long -17.66% — do not chase here.
8	GRND	WAIT	4.4	Strong fundamentals (ROE 108%, margin 18.75%) but all forecast horizons negative on every TF; bullish_prob 0.
9	DLO	WAIT	4.2	Truist raised PT to $18 but 4h pos 77.96%, 1wk pos 89.68%, and all fc_mid/long negative — extended.
10	ACMR	AVOID	3.6	Daiwa Buy at $136 is a positive, but forecasts are -47% to -69% across every horizon; bullish_prob 0.
11	TGTX	AVOID	3.4	Buyout rumors juicing price to pos 87.24% on 1wk while forecasts read -37% to -53% — do not buy the pop.
12	ARIS	AVOID	3.0	44% monthly rally leaves 1wk fc_long -72.09% and 1d fc_long -41.24%; bullish_prob 0 despite great fundamentals.
13	RSI	AVOID	2.8	Bullish_prob 0 with 1wk fc_long -57.33% and pos already 24.93% — the tape is calling a break.
14	SIMO	AVOID	2.2	+166% YTD parabolic, short interest up 80%, forecasts -60% to -77% across TFs — classic distribution setup.
15	ALM	AVOID	2.0	1wk fc_long -96.32% and P/S 82.64 after +300% year — capital-return buyback pre-ramp is a red flag, not a green light.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord